23andMe
will
pay
$30
million
to
settle
a
class
action
lawsuit
over
a
data
breach
that
affected
more
than
6.9
million
customers.
As
part
of
the
proposed
settlement,
the
genetic
testing
site
will
compensate
affected
customers
and
provide
them
with
access
to
a
security
monitoring
program
for
three
years.
23andMe
disclosed
the
data
breach
last
October,
but
it
didn’t
confirm
the
overall
impact
until
December.
Customers
using
the
DNA
Relatives
feature
may
have
had
information
like
names,
birth
years,
and
ancestry
information
exposed
through
the
breach.
At
the
time,
23andMe
attributed
the
hack
to
credential
stuffing,
a
tactic
that
involves
logging
in
to
accounts
using
recycled
logins
exposed
in
previous
security
breaches.
In
January
2024,
customers
filed
a
class
action
lawsuit
against
23andMe
in
a
San
Francisco
court,
alleging
the
company
failed
to
protect
their
privacy.
They
also
claimed
the
company
didn’t
properly
notify
customers
with
Chinese
or
Ashkenazi
Jewish
heritage
that
hackers
appeared
to
single
them
out
when
putting
information
up
for
sale
on
the
dark
web.
The
breach
dealt
a
big
blow
to
the
already
struggling
company.
As
23andMe’s
stock
price
continued
to
crater,
23andMe
CEO
Anne
Wojcicki
attempted
to
take
the
company
private
earlier
this
year,
but
the
special
committee
rejected
the
offer
last
month.
The
settlement
mentions
concerns
surrounding
the
company’s
finances,
saying,
“Any
litigated
judgment
significantly
more
than
the
Settlement
is
likely
to
be
uncollectable.”
In
a
statement
to
The
Verge,
23andMe
spokesperson
Katie
Watson
said
the
company
expects
cyber
insurance
to
cover
$25
million
of
the
settlement:
We
have
executed
a
settlement
agreement
for
an
aggregate
cash
payment
of
$30
million
to
settle
all
U.S.
claims
regarding
the
2023
credential
stuffing
security
incident.
Counsel
for
the
plaintiffs
have
filed
a
motion
for
preliminary
approval
of
this
settlement
agreement
with
the
court.
Roughly
$25
million
of
the
settlement
and
related
legal
expenses
are
expected
to
be
covered
by
cyber
insurance
coverage. We
continue
to
believe
this
settlement
is
in
the
best
interest
of
23andMe
customers,
and
we
look
forward
to
finalizing
the
agreement.
The
proposed
settlement
still
needs
approval
from
the
judge.
Original author: Emma Roth
Comments